# Treatment and Diagnostic Approach for Lhermitte-Duclos Disease and Suspected Cowden Syndrome

**Authors:** Ricardo García-Iturbide, Joel A. Velázquez, Isauro Lozano Guzmán, Jesus E Falcon-Molina, Marco A Rodríguez, Adrian Sánchez-Gómez, Jesùs R Heras Lorenzana, Eric M Estrada Estrada

PMC · DOI: 10.7759/cureus.62968 · Cureus · 2024-06-23

## TL;DR

This paper presents a case of a patient diagnosed with Lhermitte-Duclos disease and Cowden syndrome, emphasizing the importance of clinical criteria when genetic testing is not available.

## Contribution

The paper highlights the use of established clinical criteria for diagnosing Cowden syndrome in the absence of genetic confirmation.

## Key findings

- The patient was diagnosed with Cowden syndrome using clinical criteria after radiological and clinical suspicion of LDD.
- The case underscores the importance of investigating other tumors associated with PTEN hamartoma tumor syndrome.
- Clinical criteria can be sufficient for diagnosis when genetic studies are not available.

## Abstract

Lhermitte-Duclos disease (LDD) is a rare entity, which may or may not be associated with Cowden syndrome (CS). The authors present a 26-year-old male with a history of emergency treatment due to acute obstructive hydrocephalus and apparent Chiari malformation. In posterior evaluation, mild cerebellar symptoms, mucocutaneous lesions, and a left hemispheric cerebellar lesion were evident.

Initially, with the clinical evidence and the radiological study report of a cerebellar tiger-striped lesion, LDD with associated CS was suspected, and a genetic protocol was performed. The protocol included an endoscopy and thyroid ultrasound, and with symptom progression, a new neurosurgical procedure was performed. To complete the approach, we used the clinical criteria for PTEN hamartoma tumor syndrome established in 2013, and CS was diagnosed in the patient.

In patients with radiological and clinical suspicion of LDD and CS, it should be mandatory to investigate the presence of other types of tumors due to their association with PTEN hamartomatous tumor syndrome, and in the absence of genetic study, the clinical criteria previously established in the literature should be sufficient to establish the diagnosis.

## Linked entities

- **Diseases:** Lhermitte-Duclos disease (MONDO:0019002), Cowden syndrome (MONDO:0016063), PTEN hamartoma tumor syndrome (MONDO:0017623)

## Full-text entities

- **Diseases:** Chiari malformation (MESH:D001139), mucocutaneous lesions (MESH:D007897), cerebellar lesion (MESH:D002526), obstructive hydrocephalus (MESH:D006849), CS (MESH:D006223), tumors (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11265621/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11265621/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC11265621/full.md

---
Source: https://tomesphere.com/paper/PMC11265621